• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Healthcare Capital Corp. common stock (Amendment)

    12/14/21 4:28:22 PM ET
    $HCCC
    Get the next $HCCC alert in real time by email
    SC 13G/A 1 ff662040_13ga-healthcare.htm



    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C.  20549
    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*
    Healthcare Capital Corp.
    (Name of Issuer)
    Class A Common Stock, par value $0.0001 per share
    (Title of Class of Securities)
    4228C200**
    (CUSIP Number)

    October 1, 2021***
    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)
    ☑ Rule 13d-1(c)
    ☐ Rule 13d-1(d)
    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    ** Reflects the CUSIP number for the Issuer’s Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (the “Units”).

    *** The Reporting Persons previously filed an original Schedule 13G in respect of the Issuer’s Class A Common Stock, par value $0.0001 per share on January 25, 2021 (the “Original Schedule 13G”). On October 1, 2021, Corbin Capital Partners GP, LLC replaced Corbin Capital Partners Group, LLC as the general partner of each of Corbin ERISA Opportunity Fund, Ltd. and Corbin Opportunity Fund, L.P. This Amendment No. 1 to the Original Schedule 13G is being filed to reflect the fact that, as of October 1, 2021, Corbin Capital Partners Group, LLC ceased to be a reporting person, with Corbin Capital Partners GP, LLC becoming a reporting person as of that date.





    CUSIP No. 4228C200
    13G
     

    1
    NAMES OF REPORTING PERSONS
     
     
     
    Atalaya Capital Management LP
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☒
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
     
    371,250
     
     
     
     
    6
    SHARED VOTING POWER
     
     
     
    1,113,750
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
     
    371,250
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
     
    1,113,750
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
     
    1,485,000
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
     5.4%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
     IA, PN
     
     
     
     



    CUSIP No. 4228C200
    13G
     

    1
    NAMES OF REPORTING PERSONS
     
     
     
    Corbin ERISA Opportunity Fund, Ltd.
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☒
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
     
    Cayman Islands
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
     0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
     
    742,500
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
     0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
     
    742,500
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
    742,500
     
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
     2.7%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
     OO
     
     
     
     



    CUSIP No. 4228C200
    13G
     

    1
    NAMES OF REPORTING PERSONS
     
     
     
    Corbin Capital Partners GP, LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☒
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
     0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
     
    1,113,750
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
     0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
     
    1,113,750
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
     
    1,113,750
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
     4,1%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
     OO
     
     
     
     



    CUSIP No. 4228C200
    13G
     

    1
    NAMES OF REPORTING PERSONS
     
     
     
    Corbin Capital Partners Group, LLC
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☒
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
     0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
     0
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
     0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
     0
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
     
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
     0%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
     OO
     
     
     
     


     
     

    CUSIP No. 4228C200
    13G
     

    1
    NAMES OF REPORTING PERSONS
     
     
     
    Corbin Capital Partners, L.P.
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☒
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
     0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
     
    1,113,750
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
     0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
     
    1,113,750
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
     
    1,113,750
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
     4.1%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
     IA, PN
     
     
     
     


     

    CUSIP No. 4228C200
    13G
     

    1
    NAMES OF REPORTING PERSONS
     
     
     
    Corbin Opportunity Fund, L.P.
     
     
     
     
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
       
    (a)☒
       
    (b)☐
     
     
    3
    SEC USE ONLY
     
     
     
     
     
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
     
     
    Delaware
     
     
     
     
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
     
     0
     
     
     
     
    6
    SHARED VOTING POWER
     
     
     
    371,250
     
     
     
     
    7
    SOLE DISPOSITIVE POWER
     
     
     0
     
     
     
     
    8
    SHARED DISPOSITIVE POWER
     
     
     
    371,250
     
     
     
     
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
     
     
    371,250
     
     
     
     
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
     
     
    ☐
     
     
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
     
     1.4%
     
     
     
     
    12
    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
     
     
     PN
     
     
     
     


     
    Explanatory Note

    The Reporting Persons previously filed an original Schedule 13G in respect of the Issuer’s Class A Common Stock, par value $0.0001 per share on January 25, 2021 (the “Original Schedule 13G”). On October 1, 2021, Corbin Capital Partners GP, LLC replaced Corbin Capital Partners Group, LLC as the general partner of each of Corbin ERISA Opportunity Fund, Ltd. and Corbin Opportunity Fund, L.P. This Amendment No. 1 to the Original Schedule 13G is being filed to reflect the fact that, as of October 1, 2021, Corbin Capital Partners Group, LLC ceased to be a reporting person, with Corbin Capital Partners GP, LLC becoming a reporting person as of that date.

    Item 1.(a) Name of Issuer

    Healthcare Capital Corp.

    Item 1.(b) Address of Issuer’s Principal Executive Offices

    301 North Market Street, Suite 1414, Wilmington, DE 19801

    Item 2.(a) Name of Person Filing

    This Statement is filed on behalf of the following persons (collectively, the “Reporting Persons”):

    (i)
    Atalaya Capital Management LP (“ACM”);
    (ii)
    Corbin ERISA Opportunity Fund, Ltd. (“CEOF”);
    (iii)
    Corbin Capital Partners GP, LLC (“Corbin GP”);
    (iv)
    Corbin Capital Partners Group, LLC (“CCPG”);
    (v)
    Corbin Capital Partners, L.P. (“CCP”); and
    (vi)
    Corbin Opportunity Fund, L.P. (“COF”).

    ACM serves as sub-advisor to CEOF and COF, and in such capacity, exercises discretionary investment authority over the Shares (as defined below) underlying Units held directly by CEOF and COF.

    Item 2.(b) Address of Principal Business Office or, if None, Residence

    The address of the principal business office of ACM is One Rockefeller Plaza, 32nd Floor, New York, NY 10020. The address of the principal business office of each of CEOF, Corbin GP, CCPG, CCP, and COF is 590 Madison Avenue, 31st Floor, New York, NY 10022.

    Item 2.(c) Citizenship

    Each of ACM, CCP and COF is a Delaware limited partnership. CEOF is a Cayman Islands exempted company. Each of Corbin GP and CCPG is a Delaware limited liability company.
    Item 2.(d) Title of Class of Securities

    Class A Common Stock, par value $0.0001 per share (the “Shares”).

    Item 2.(e) CUSIP Number

    4228C200

    Item 3.    If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

    This Item 3 is not applicable.

    Item 4(a). Amount Beneficially Owned:

    As of the date hereof, ACM may be deemed the beneficial owner of 1,485,000 Shares underlying Units, which amount includes (i) the 742,500 Shares underlying Units beneficially owned by CEOF, and (ii) the 371,250 Shares underlying Units beneficially owned by COF. Each of Corbin GP and CCP may be deemed the beneficial owner of 1,113,750 Shares underlying Units. As of October 1, 2021, CCPG ceased to beneficially own any Shares.

    Item 4(b). Percent of Class:

    As of the date hereof, ACM may be deemed the beneficial owner of approximately 5.4% of Shares outstanding, which amount includes (i) the 2.7% of Shares outstanding beneficially owned by CEOF, and (ii) the 1.4% of Shares outstanding beneficially owned by COF. Each of Corbin GP and CCP may be deemed the beneficial owner of approximately 4.1% of Shares outstanding. (These percentages are based on 27,500,000 Shares outstanding as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission on November 15, 2021.)

    Item 4(c). Number of shares as to which such person has:

    ACM:
    (i) Sole power to vote or to direct the vote: 371,250
    (ii) Shared power to vote or to direct the vote: 1,113,750
    (iii) Sole power to dispose or to direct the disposition of: 371,250
    (iv) Shared power to dispose or to direct the disposition of: 1,113,750

    CEOF:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 742,500
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 742,500

    Corbin GP:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 1,113,750
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 1,113,750

    CCPG:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 0
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 0

    CCP:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 1,113,750
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 1,113,750

    COF:
    (i) Sole power to vote or to direct the vote: 0
    (ii) Shared power to vote or to direct the vote: 371,250
    (iii) Sole power to dispose or to direct the disposition of: 0
    (iv) Shared power to dispose or to direct the disposition of: 371,250

    Item 5.  Ownership of Five Percent or Less of a Class

    As of October 1, 2021, CCPG ceased to beneficially own any Shares and this Amendment No. 1 serves as an exit filing for CCPG.

    Item 6.  Ownership of More than Five Percent on Behalf of Another Person

    This Item 6 is not applicable.

    Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company

    This Item 7 is not applicable.

    Item 8.  Identification and Classification of Members of the Group

    ACM, CEOF, Corbin GP, CCP, and COF may be deemed members of a group, as defined in Rule 13d-5 under the Act, with respect to the Shares. Such group may be deemed to beneficially own 1,485,000 Shares. CEOF, Corbin GP and CCP disclaim beneficial ownership over the Shares held directly by ACM.

    Item 9.  Notice of Dissolution of Group

    As of October 1, 2021, CCPG ceased to beneficially own any Shares and, as of that date, ceased to be a member of a group with the other Reporting Persons with respect to the Issuer’s Shares.

    Item 10.   Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated:  December 14, 2021
     

     
    Atalaya Capital Management LP
     
     
     
    By:
     /s/ Drew Phillips
     
     
    Name:
     Drew Phillips
     
     
    Title:
    Authorized Signatory
     


     
    Corbin ERISA Opportunity Fund, Ltd.
     
     
     
    By:
    Corbin Capital Partners, L.P.
     
     
    Its:
    Investment Manager
     
           
     
    By:
     /s/ Daniel Friedman
     
     
    Name:
     Daniel Friedman
     
     
    Title:
     General Counsel
     


     
    Corbin Capital Partners GP, LLC
     
     
     
    By:
     /s/ Daniel Friedman
     
     
    Name:
     Daniel Friedman
     
     
    Title:
     Authorized Signatory
     


     
    Corbin Capital Partners Group, LLC
     
     
     
    By:
     /s/ Daniel Friedman
     
     
    Name:
     Daniel Friedman
     
     
    Title:
     Authorized Signatory
     


     
    Corbin Capital Partners, L.P.
     
     
     
    By:
     /s/ Daniel Friedman
     
     
    Name:
     Daniel Friedman
     
     
    Title:
     General Counsel
     


     
    Corbin Opportunity Fund, Ltd.
     
     
     
    By:
    Corbin Capital Partners, L.P.
     
     
    Its:
    Investment Manager
     
           
     
    By:
     /s/ Daniel Friedman
     
     
    Name:
     Daniel Friedman
     
     
    Title:
     General Counsel
     

     



    JOINT FILING AGREEMENT

     The undersigned hereby agree that this Amendment No. 1 to the statement on Schedule 13G with respect to shares of Class A Common Stock, par value $0.0001 of Healthcare Capital Corp. is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
     
    Dated:  December 14, 2021


     
    Atalaya Capital Management LP
     
     
     
    By:
     /s/ Drew Phillips
     
     
    Name:
     Drew Phillips
     
     
    Title:
    Authorized Signatory
     


     
    Corbin ERISA Opportunity Fund, Ltd.
     
     
     
    By:
    Corbin Capital Partners, L.P.
     
     
    Its:
    Investment Manager
     
           
     
    By:
     /s/ Daniel Friedman
     
     
    Name:
     Daniel Friedman
     
     
    Title:
     General Counsel
     


     
    Corbin Capital Partners GP, LLC
     
     
     
    By:
     /s/ Daniel Friedman
     
     
    Name:
     Daniel Friedman
     
     
    Title:
     Authorized Signatory
     


     
    Corbin Capital Partners Group, LLC
     
     
     
    By:
     /s/ Daniel Friedman
     
     
    Name:
     Daniel Friedman
     
     
    Title:
     Authorized Signatory
     


     
    Corbin Capital Partners, L.P.
     
     
     
    By:
     /s/ Daniel Friedman
     
     
    Name:
     Daniel Friedman
     
     
    Title:
     General Counsel
     


     
    Corbin Opportunity Fund, Ltd.
     
     
     
    By:
    Corbin Capital Partners, L.P.
     
     
    Its:
    Investment Manager
     
           
     
    By:
     /s/ Daniel Friedman
     
     
    Name:
     Daniel Friedman
     
     
    Title:
     General Counsel
     

    Get the next $HCCC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCCC

    DatePrice TargetRatingAnalyst
    1/24/2022$18.00Buy
    Ladenburg Thalmann
    More analyst ratings

    $HCCC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ladenburg Thalmann initiated coverage on Healthcare Capital with a new price target

    Ladenburg Thalmann initiated coverage of Healthcare Capital with a rating of Buy and set a new price target of $18.00

    1/24/22 7:16:23 AM ET
    $HCCC

    $HCCC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination

    JERUSALEM and WILMINGTON, Del., March 7, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and Healthcare Capital Corp. (NASDAQ:HCCC) ("HCCC"), a special purpose acquisition company, announced today the successful closing of the previously announced business combination (the "Business Combination"). The combined company will continue to be led by Alpha Tau's existing management team. Alpha Tau's ordinary shares and warrants are expected to begin trading on Tuesday, March 8, 2022, on Nasdaq under the ticker symbols "DRTS" and "DRTSW," respectively. The transaction, and the various proposals giving effect ther

    3/7/22 8:32:00 AM ET
    $HCCC

    Healthcare Capital Corp. and Alpha Tau Medical Ltd. Announce Stockholder Approval of the Business Combination

    NEW YORK and JERUSALEM, ISRAEL , Feb. 22, 2022 (GLOBE NEWSWIRE) --  Healthcare Capital Corp. (NASDAQ:HCCC, HCCCW, and HCCCU))) ("HCCC") and Alpha Tau Medical Ltd. ("Alpha Tau"), an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors, today announced that in its special meeting held on February 18, 2022, HCCC's stockholders voted to approve the previously announced proposed business combination (the "Business Combination") of HCCC and Alpha Tau. Approximately 94.57% of the votes cast at the meeting, representing approximately 65.64% of HCCC's outstanding shares as of the record date, voted

    2/22/22 7:30:00 AM ET
    $HCCC

    Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders

    NEW YORK, NY, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (NASDAQ:HCCC, HCCCW, and HCCCU))) ("HCCC") today announced that on February 18, 2022, it convened and then adjourned, without conducting any other business, its special meeting of stockholders (the "Special Meeting"). The Special Meeting has been adjourned until February 18, 2022 at 4:00p.m. Eastern Time (the "Adjournment"). The Special Meeting is being held to approve the business combination (the "Business Combination") with Alpha Tau Medical Ltd. ("Alpha Tau") and related proposals, as described in HCCC's definitive proxy statement filed with the Securities and Exchange Commission ("SEC") on January 14, 2022. The

    2/18/22 11:38:11 AM ET
    $HCCC

    $HCCC
    SEC Filings

    View All

    SEC Form 25-NSE filed by Healthcare Capital Corp.

    25-NSE - Healthcare Capital Corp/DE (0001822935) (Subject)

    3/7/22 4:22:12 PM ET
    $HCCC

    Healthcare Capital Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - Healthcare Capital Corp/DE (0001822935) (Filer)

    2/22/22 4:05:34 PM ET
    $HCCC

    SEC Form 425 filed by Healthcare Capital Corp.

    425 - Healthcare Capital Corp/DE (0001822935) (Subject)

    2/18/22 1:10:14 PM ET
    $HCCC

    $HCCC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Milch David Mark converted options into 1,923,925 shares and disposed of 1,923,925 shares

    4 - Healthcare Capital Corp/DE (0001822935) (Issuer)

    3/9/22 9:30:25 PM ET
    $HCCC

    SEC Form 4: Doyle Michael was granted 2,500 units of Common Stock

    4 - VISION HYDROGEN Corp (0001676580) (Issuer)

    5/14/21 1:08:25 PM ET
    $HCCC

    SEC Form 4: BENTON CHARLES F was granted 2,500 units of Common Stock

    4 - VISION HYDROGEN Corp (0001676580) (Issuer)

    5/14/21 1:06:11 PM ET
    $HCCC

    $HCCC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Healthcare Capital Corp. (Amendment)

    SC 13G/A - Healthcare Capital Corp/DE (0001822935) (Subject)

    3/9/22 11:16:23 AM ET
    $HCCC

    SEC Form SC 13G filed by Healthcare Capital Corp.

    SC 13G - Healthcare Capital Corp/DE (0001822935) (Subject)

    2/18/22 4:13:27 PM ET
    $HCCC

    SEC Form SC 13G filed by Healthcare Capital Corp.

    SC 13G - Healthcare Capital Corp/DE (0001822935) (Subject)

    2/14/22 4:01:26 PM ET
    $HCCC